Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000711377-26-000002
Filing Date
2026-01-26
Accepted
2026-01-26 09:22:25
Documents
1
Period of Report
2026-01-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1479
  Complete submission text file 0000711377-26-000002.txt   2858
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address
Ranalli Tamara A. (Reporting) CIK: 0001822508 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17988 | Film No.: 26558663